HIGHLIGHTS
- who: Vaibhav Koutu and collaborators from the (UNIVERSITY) have published the research: Review began 01/12/2023 Review ended 01/20/2023 Published 01/26/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/26,/2023
- how: This article presents a narrative review of approved nanomedicines in lung cancer with a special focus on the results of recently concluded and ongoing clinical trials.
SUMMARY
And Background Cancer has been the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 which means nearly one in every six deaths . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.